rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-4-23
|
pubmed:abstractText |
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Ibuprofen is a nonsteroidal anti-inflammatory agent that induces closure of the patent ductus arteriosus in neonates. Few studies of ibuprofen pharmacokinetics have been performed and were limited to small groups of preterm infants, showing a large intersubject variability and an increase in clearance with either postnatal or gestational age.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1365-2125
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
629-36
|
pubmed:dateRevised |
2011-1-11
|
pubmed:meshHeading |
pubmed-meshheading:18307541-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:18307541-Area Under Curve,
pubmed-meshheading:18307541-Ductus Arteriosus, Patent,
pubmed-meshheading:18307541-Humans,
pubmed-meshheading:18307541-Ibuprofen,
pubmed-meshheading:18307541-Infant, Newborn,
pubmed-meshheading:18307541-Infant, Premature,
pubmed-meshheading:18307541-Infant, Very Low Birth Weight,
pubmed-meshheading:18307541-Infusions, Intravenous,
pubmed-meshheading:18307541-Logistic Models,
pubmed-meshheading:18307541-Lysine,
pubmed-meshheading:18307541-Respiratory Distress Syndrome, Newborn
|
pubmed:year |
2008
|
pubmed:articleTitle |
An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
|
pubmed:affiliation |
EA3620, Université Paris - Descartes, Paris, France. deborah.hirt@univ-paris5.fr
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|